Clinical Trials
4
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (100.0%)Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
Not Applicable
Completed
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2015-12-17
- Last Posted Date
- 2020-08-28
- Lead Sponsor
- Genomind, LLC
- Target Recruit Count
- 305
- Registration Number
- NCT02634177
- Locations
- 🇺🇸
University of Alabama - Birmingham, Birmingham, Alabama, United States
🇺🇸Noesis Pharma, Phoenix, Arizona, United States
🇺🇸Woodland Research Northwest, Springdale, Arkansas, United States
An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay
Not Applicable
Completed
- Conditions
- Treatment Resistant DepressionGeneralized Anxiety Disorder
- First Posted Date
- 2012-01-10
- Last Posted Date
- 2016-06-08
- Lead Sponsor
- Genomind, LLC
- Target Recruit Count
- 685
- Registration Number
- NCT01507155
- Locations
- 🇺🇸
Genomind, LLC, Chalfont, Pennsylvania, United States
An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression
Not Applicable
Withdrawn
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2011-09-22
- Last Posted Date
- 2015-03-23
- Lead Sponsor
- Genomind, LLC
- Registration Number
- NCT01438242
- Locations
- 🇺🇸
Genomind, LLC, Chalfont, Pennsylvania, United States
Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)
Not Applicable
Terminated
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2011-08-31
- Last Posted Date
- 2021-09-13
- Lead Sponsor
- Genomind, LLC
- Target Recruit Count
- 29
- Registration Number
- NCT01426516
- Locations
- 🇺🇸
Centerstone, Nashville, Tennessee, United States
News
No news found